According to this study, the global Neurodegenerative Disease market size will reach US$ 9061 million by 2031.

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimers disease, Parkinsons disease, and amyotrophic lateral sclerosis (ALS).

The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The markets growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.

LPI (LP Information) newest research report, the Neurodegenerative Disease Industry Forecast looks at past sales and reviews total world Neurodegenerative Disease sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurodegenerative Disease sales for 2025 through 2031. With Neurodegenerative Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurodegenerative Disease industry.

This Insight Report provides a comprehensive analysis of the global Neurodegenerative Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurodegenerative Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Neurodegenerative Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurodegenerative Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurodegenerative Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurodegenerative Disease market by product type, application, key players and key regions and countries.

Segmentation by Type:

    NMDA
    SSRIs
    Dopamine Inhibitors

Segmentation by Application:

    Parkinsons Disease
    Huntington Disease
    Amyotrophic Lateral Sclerosis
    Alzheimers Disease

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Novartis
    Pfizer
    Merck Serono
    Biogen Idec
    TEVA
    UCB
    Boehringer Ingelheim
    Sanofi
    GlaxoSmithKline
    Livzon Pharmaceutical
    Haisco Pharmaceutical
    Jingxin Pharmaceutical
    Dongcheng Biochemicals
    Hisun Pharmaceutical
    Luye Pharma
    Ark Pharmaceutical
    Kanghong Pharmaceutical
    Huahai Pharmaceutical
    BORA PHARMACEUTICALS